Prometheus Biosciences
RXDX
#2010
Rank
ยฃ7.14 B
Marketcap
ยฃ149.36
Share price
0.00%
Change (1 day)
332.80%
Change (1 year)

Revenue for Prometheus Biosciences (RXDX)

Revenue in 2023 (TTM): ยฃ3.34 Million

According to Prometheus Biosciences's latest financial reports the company's current revenue (TTM ) is ยฃ2.98 Million. In 2022 the company made a revenue of ยฃ5.62 Million an increase over the revenue in the year 2021 that were of ยฃ2.31 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prometheus Biosciences from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ3.34 M-40.51%
2022 ยฃ5.62 M142.8%
2021 ยฃ2.31 M157.09%
2020 ยฃ0.9 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Epizyme
EPZM
ยฃ39.6 M 1,226.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ79.8 M 2,574.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Akebia Therapeutics
AKBA
ยฃ0.16 B 5,533.82%๐Ÿ‡บ๐Ÿ‡ธ USA